Bringing the fundamentals into focus…
Back to DENTSPLY SIRONA Inc.
How DENTSPLY SIRONA Inc. stacks up
XRAY · against 415 other Healthcare companies of similar size
Valuation
66/ 100
Above the middle of the pack.
Ranked #155 of 416 · scores higher than 62% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 60–69, including XRAY · Click a bar to see the companies
Why valuation scores 66?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -28.1% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 88% of peers. EBITDA yield: 13.1% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 89% of peers. Free cash flow yield: 7.4% vs peer median 0.0%
Metric by metric
Position: dot = XRAY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | XRAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 404 reported | -28.1% | 1.7% | 3% | 30% | |
| EBITDA yieldHigher is better · 415 reported | 13.1% | 4.5% | 90% | 50% | |
| Free cash flow yieldHigher is better · 191 reported | 7.4% | -0.5% | 87% | 20% | |
| Book yieldHigher is better · 406 reported | 67.6% | 35.1% | 80% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around XRAYScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score